218 related articles for article (PubMed ID: 34608568)
1. miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1.
Sheng S; Zou M; Yang Y; Guan M; Ren S; Wang X; Wang L; Xue Y
In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):763-774. PubMed ID: 34608568
[TBL] [Abstract][Full Text] [Related]
2. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
[TBL] [Abstract][Full Text] [Related]
3. miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1.
Liu F; Zhang ZP; Xin GD; Guo LH; Jiang Q; Wang ZX
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4252-4260. PubMed ID: 30024615
[TBL] [Abstract][Full Text] [Related]
4. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
[TBL] [Abstract][Full Text] [Related]
6. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
7. Satellite cell-derived exosome-mediated delivery of microRNA-23a/27a/26a cluster ameliorates the renal tubulointerstitial fibrosis in mouse diabetic nephropathy.
Ji JL; Shi HM; Li ZL; Jin R; Qu GT; Zheng H; Wang E; Qiao YY; Li XY; Ding L; Ding DF; Ding LC; Gan WH; Wang B; Zhang AQ
Acta Pharmacol Sin; 2023 Dec; 44(12):2455-2468. PubMed ID: 37596398
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Rab27a in renal tubular epithelial cells attenuates the inflammation of diabetic kidney disease through the miR-26a-5p/CHAC1/NF-kB pathway.
Li S; Jia Y; Xue M; Hu F; Zheng Z; Zhang S; Ren S; Yang Y; Si Z; Wang L; Guan M; Xue Y
Life Sci; 2020 Nov; 261():118347. PubMed ID: 32853650
[TBL] [Abstract][Full Text] [Related]
9. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
[TBL] [Abstract][Full Text] [Related]
10. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
[TBL] [Abstract][Full Text] [Related]
11. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
[TBL] [Abstract][Full Text] [Related]
12. MiR-4756 promotes albumin-induced renal tubular epithelial cell epithelial-to-mesenchymal transition and endoplasmic reticulum stress via targeting Sestrin2.
Jia Y; Zheng Z; Yang Y; Zou M; Li J; Wang L; Guan M; Xue Y
J Cell Physiol; 2019 Mar; 234(3):2905-2915. PubMed ID: 30145827
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-494-3p Exacerbates Renal Epithelial Cell Dysfunction by Targeting SOCS6 under High Glucose Treatment.
Xue X; Liu M; Wang Y; Yang Y; Li Z; Shi R; Miao Y
Kidney Blood Press Res; 2022; 47(4):247-255. PubMed ID: 35038704
[TBL] [Abstract][Full Text] [Related]
14. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease.
Wang Y; Zheng ZJ; Jia YJ; Yang YL; Xue YM
J Transl Med; 2018 May; 16(1):146. PubMed ID: 29848325
[TBL] [Abstract][Full Text] [Related]
15. hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy.
Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W
Oxid Med Cell Longev; 2021; 2021():8814163. PubMed ID: 34257820
[TBL] [Abstract][Full Text] [Related]
16. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the lncRNA
Zhang B; Zhao C; Hou L; Wu Y
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
[TBL] [Abstract][Full Text] [Related]
18. Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease.
Hu F; Xue M; Li Y; Jia YJ; Zheng ZJ; Yang YL; Guan MP; Sun L; Xue YM
J Diabetes Res; 2018; 2018():3405695. PubMed ID: 29854821
[TBL] [Abstract][Full Text] [Related]
19. miR-23a-3p inhibits sepsis-induced kidney epithelial cell injury by suppressing Wnt/β-catenin signaling by targeting wnt5a.
Ye J; Feng H; Peng Z
Braz J Med Biol Res; 2022; 55():e11571. PubMed ID: 35239776
[TBL] [Abstract][Full Text] [Related]
20. LncRNA GAS5 exacerbates renal tubular epithelial fibrosis by acting as a competing endogenous RNA of miR-96-5p.
Wang W; Jia YJ; Yang YL; Xue M; Zheng ZJ; Wang L; Xue YM
Biomed Pharmacother; 2020 Jan; 121():109411. PubMed ID: 31810140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
